Literature DB >> 29883190

Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance Use.

Maxine L Stitzer1, Alexis S Hammond1, Tim Matheson2, James L Sorensen3, Daniel J Feaster4, Rui Duan4, Lauren Gooden5, Carlos Del Rio6, Lisa R Metsch5.   

Abstract

This secondary analysis compares health behavior outcomes for two groups of HIV+ substance users randomized in a 3-arm trial [1] to receive Patient Navigation with (PN+CM) or without (PN) contingent financial incentives (CM). Mean age of participants was 45 years; the majority was male (67%), African American (78%), unemployed (35%), or disabled (50%). Behaviors incentivized for PN+CM were (1) attendance at HIV care visits and (2) verification of an active HIV medication prescription. Incentives were associated with shorter time to treatment initiation and higher rates of behaviors during the 6-month intervention with exception of month 6 HIV care visits. Median HIV care visits were 3 (IQR 2-4) for PN+CM versus 1.5 (IQR 0-3) for PN (Wilcoxon p < 0.001); median validated medication checks were 4 (IQR 2-6) for PN+CM versus 1 (IQR 0-3) for PN (Wilcoxon p < 0.001). Viral suppression rates at end of treatment were not significantly different for the two groups but were directly related to the number of behaviors completed for both care visits (χ2(1) = 7.69, p = 0.006) and validated medication (χ2(1) = 8.49, p = 0.004). Results support use of incentives to increase performance of key healthcare behaviors. Adjustments to the incentive program may be needed to achieve greater rates of sustained health behavior change that result in improved viral load outcomes.

Entities:  

Keywords:  HIV healthcare; contingency management; medication adherence; patient navigation; substance users; viral suppression

Mesh:

Year:  2018        PMID: 29883190      PMCID: PMC6034401          DOI: 10.1089/apc.2018.0014

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  30 in total

1.  Randomized trial of lottery-based incentives to improve warfarin adherence.

Authors:  Stephen E Kimmel; Andrea B Troxel; George Loewenstein; Colleen M Brensinger; Jane Jaskowiak; Jalpa A Doshi; Mitchell Laskin; Kevin Volpp
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

2.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Authors:  James L Sorensen; Nancy A Haug; Kevin L Delucchi; Valerie Gruber; Evan Kletter; Steven L Batki; Jacqueline P Tulsky; Paul Barnett; Sharon Hall
Journal:  Drug Alcohol Depend       Date:  2006-10-23       Impact factor: 4.492

4.  Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.

Authors:  David A Wohl; Rita K Kuwahara; Kamran Javadi; Christine Kirby; David L Rosen; Sonia Napravnik; Claire Farel
Journal:  AIDS Patient Care STDS       Date:  2017-10-17       Impact factor: 5.078

5.  A cross-site, comparative effectiveness study of an integrated HIV and substance use treatment program.

Authors:  Rae Jean Proeschold-Bell; Amy Heine; Brian Wells Pence; Keith McAdam; Evelyn Byrd Quinlivan
Journal:  AIDS Patient Care STDS       Date:  2010-10       Impact factor: 5.078

6.  Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial.

Authors:  Marjan Javanbakht; Paul Prosser; Tim Grimes; Michael Weinstein; Charles Farthing
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2006-12

7.  Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India.

Authors:  Sunil Suhas Solomon; Aylur K Srikrishnan; Canjeevaram K Vasudevan; Santhanam Anand; Muniratnam Suresh Kumar; Pachamuthu Balakrishnan; Shruti H Mehta; Suniti Solomon; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2014-05-06       Impact factor: 9.079

8.  The therapeutic implications of timely linkage and early retention in HIV care.

Authors:  Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero
Journal:  AIDS Patient Care STDS       Date:  2009-01       Impact factor: 5.078

9.  Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).

Authors:  Wafaa M El-Sadr; Deborah Donnell; Geetha Beauchamp; H Irene Hall; Lucia V Torian; Barry Zingman; Garret Lum; Michael Kharfen; Richard Elion; Jason Leider; Fred M Gordin; Vanessa Elharrar; David Burns; Allison Zerbe; Theresa Gamble; Bernard Branson
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

10.  A test of financial incentives to improve warfarin adherence.

Authors:  Kevin G Volpp; George Loewenstein; Andrea B Troxel; Jalpa Doshi; Maureen Price; Mitchell Laskin; Stephen E Kimmel
Journal:  BMC Health Serv Res       Date:  2008-12-23       Impact factor: 2.655

View more
  6 in total

1.  Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use.

Authors:  Maxine L Stitzer; Natalie Gukasyan; Tim Matheson; James L Sorensen; Daniel J Feaster; Rui Duan; Lauren Gooden; Carlos Del Rio; Lisa R Metsch
Journal:  Psychol Addict Behav       Date:  2019-08-22

2.  A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study.

Authors:  Kathleen M Ward; Oluwaseun Falade-Nwulia; Juhi Moon; Catherine G Sutcliffe; Sherilyn Brinkley; Taryn Haselhuhn; Stephanie Katz; Kayla Herne; Lilian Arteaga; Shruti H Mehta; Carl Latkin; Robert K Brooner; Mark S Sulkowski
Journal:  Open Forum Infect Dis       Date:  2019-04-09       Impact factor: 3.835

3.  How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.

Authors:  Shannon Gwin Mitchell; Laura B Monico; Maxine Stitzer; Timothy Matheson; James L Sorensen; Daniel J Feaster; Robert P Schwartz; Lisa Metsch
Journal:  J Subst Abuse Treat       Date:  2018-07-22

Review 4.  Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review.

Authors:  Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-05       Impact factor: 5.495

5.  Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.

Authors:  Sharleen M Traynor; Lisa R Metsch; Lauren Gooden; Maxine Stitzer; Tim Matheson; Susan Tross; Adam W Carrico; Mamta K Jain; Carlos Del Rio; Daniel J Feaster
Journal:  Drug Alcohol Depend       Date:  2021-02-03       Impact factor: 4.492

6.  A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study.

Authors:  E Jennifer Edelman; James Dziura; Yanhong Deng; Krysten W Bold; Sean M Murphy; Elizabeth Porter; Keith M Sigel; Jessica E Yager; David M Ledgerwood; Steven L Bernstein
Journal:  Contemp Clin Trials       Date:  2021-03-29       Impact factor: 2.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.